PHARMACOKINETICS AND METABOLIC EFFECTS OF GLIBENCLAMIDE AND GLIPIZIDE IN TYPE-2 DIABETICS

被引:58
作者
GROOP, L
WAHLINBOLL, E
GROOP, PH
TOTTERMAN, KJ
MELANDER, A
TOLPPANEN, EM
FYHRQVIST, F
机构
[1] UNIV HELSINKI,DEPT MED 3,SF-00170 HELSINKI 17,FINLAND
[2] UNIV HELSINKI,DEPT MED 4,SF-00170 HELSINKI 17,FINLAND
[3] LUND UNIV,HLTH SCI CTR,DIV CLIN PHARMACOL,DALBY,SWEDEN
关键词
D O I
10.1007/BF00607919
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:697 / 704
页数:8
相关论文
共 35 条
[1]   SIGNIFICANCE AND INTERPRETATION OF MILDLY ABNORMAL ORAL GLUCOSE TOLERANCE [J].
ALFORD, FP ;
MARTIN, FIR ;
PEARSON, MJ .
DIABETOLOGIA, 1971, 7 (03) :173-+
[2]   INFLUENCE OF SULFONYLUREAS ON THE SECRETION, DISPOSAL AND EFFECT OF INSULIN [J].
ALMER, LO ;
JOHANSSON, E ;
MELANDER, A ;
WAHLINBOLL, E .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (01) :27-32
[3]   CLINICAL PHARMACOKINETICS OF SULFONYLUREA HYPOGLYCEMIC DRUGS [J].
BALANT, L .
CLINICAL PHARMACOKINETICS, 1981, 6 (03) :215-241
[4]   INCREASED INSULIN SENSITIVITY AND CELLULAR INSULIN BINDING IN OBESE DIABETICS FOLLOWING TREATMENT WITH GLIBENCLAMIDE [J].
BECKNIELSEN, H ;
PEDERSEN, O ;
LINDSKOV, HO .
ACTA ENDOCRINOLOGICA, 1979, 90 (03) :451-462
[5]  
CREUTZFELDT W, 1977, DIABETES, P63
[6]  
DeFronzo R A, 1983, Am J Med, V74, P52, DOI 10.1016/0002-9343(83)90654-X
[7]  
DIXON WJ, 1981, BMDP STATISTICAL SOF
[8]   STIMULATION OF INSULIN-SECRETION BY GASTRIC INHIBITORY POLYPEPTIDE IN MAN [J].
DUPRE, J ;
ROSS, SA ;
WATSON, D ;
BROWN, JC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1973, 37 (05) :826-828
[9]   KINETICS OF HUMAN CONNECTING PEPTIDE IN NORMAL AND DIABETIC SUBJECTS [J].
FABER, OK ;
HAGEN, C ;
BINDER, C ;
MARKUSSEN, J ;
NAITHANI, VK ;
BLIX, PM ;
KUZUYA, H ;
HORWITZ, DL ;
RUBENSTEIN, AH ;
ROSSING, N .
JOURNAL OF CLINICAL INVESTIGATION, 1978, 62 (01) :197-203
[10]   SULFONYLUREAS INCREASE NUMBER OF INSULIN RECEPTORS [J].
FEINGLOS, MN ;
LEBOVITZ, HE .
NATURE, 1978, 276 (5684) :184-185